159 related articles for article (PubMed ID: 15284121)
1. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells.
Hall AM; Vickers MA; McLeod E; Barker RN
Blood; 2005 Mar; 105(5):2007-15. PubMed ID: 15284121
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A
Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517
[TBL] [Abstract][Full Text] [Related]
3. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia.
Efremov DG; Ivanovski M; Burrone OR
Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500
[TBL] [Abstract][Full Text] [Related]
4. Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia.
Barker RN; Hall AM; Standen GR; Jones J; Elson CJ
Blood; 1997 Oct; 90(7):2701-15. PubMed ID: 9326237
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune complications of chronic lymphocytic leukemia.
Hamblin TJ
Semin Oncol; 2006 Apr; 33(2):230-9. PubMed ID: 16616070
[TBL] [Abstract][Full Text] [Related]
6. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
7. Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.
Zhu H; Xu W; Liu H; Wang H; Fu R; Wu Y; Qu W; Wang G; Guan J; Song J; Xing L; Shao Z
Int J Hematol; 2016 May; 103(5):545-53. PubMed ID: 26968550
[TBL] [Abstract][Full Text] [Related]
8. Etiopathogenesis and prognostic implications of autoimmune hemolytic anemia association with chronic lymphocytic leukemia B.
Oprea MM; Ivanescu AM; Colita A; Coles E; Momanu RC; Berbec N; Lupu AR
J Med Life; 2012; 5(Spec Issue):44-47. PubMed ID: 31803285
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies.
Bröker BM; Klajman A; Youinou P; Jouquan J; Worman CP; Murphy J; Mackenzie L; Quartey-Papafio R; Blaschek M; Collins P
J Autoimmun; 1988 Oct; 1(5):469-81. PubMed ID: 2473761
[TBL] [Abstract][Full Text] [Related]
10. Broad alterations of self-reactive antibody-repertoires of plasma IgM and IgG in B-cell chronic lymphocytic leukemia (B-CLL) and B-CLL related target-restricted autoimmunity.
Stahl D; Lacroix-Desmazes S; Sibrowski W; Kazatchkine MD; Kaveri SV
Leuk Lymphoma; 2001 Jun; 42(1-2):163-76. PubMed ID: 11699204
[TBL] [Abstract][Full Text] [Related]
11. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
12. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
Sthoeger ZM; Wakai M; Tse DB; Vinciguerra VP; Allen SL; Budman DR; Lichtman SM; Schulman P; Weiselberg LR; Chiorazzi N
J Exp Med; 1989 Jan; 169(1):255-68. PubMed ID: 2462608
[TBL] [Abstract][Full Text] [Related]
13. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia.
Efremov DG; Ivanovski M; Siljanovski N; Pozzato G; Cevreska L; Fais F; Chiorazzi N; Batista FD; Burrone OR
Blood; 1996 May; 87(9):3869-76. PubMed ID: 8611714
[TBL] [Abstract][Full Text] [Related]
14. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
16. Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method.
Barker RN; Casswell KM; Reid ME; Sokol RJ; Elson CJ
Br J Haematol; 1992 Sep; 82(1):126-32. PubMed ID: 1419786
[TBL] [Abstract][Full Text] [Related]
17. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serological autoimmune complications in chronic lymphocytic leukemia.
Demir C; Ekinci Ö
Wien Klin Wochenschr; 2017 Aug; 129(15-16):552-557. PubMed ID: 28477093
[TBL] [Abstract][Full Text] [Related]
19. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
Shirai T
Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
[TBL] [Abstract][Full Text] [Related]
20. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.
Mayr C; Bund D; Schlee M; Bamberger M; Kofler DM; Hallek M; Wendtner CM
Exp Hematol; 2006 Jan; 34(1):44-53. PubMed ID: 16413390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]